Trump's move to withdraw from WHO cited dissatisfaction with pandemic responses Experts warn of reduced U.S. influence in global health initiatives WHO’s collaborative efforts remain crucial for ...
The three-day conference will address crucial topics related to pharmaceutical regulation, impurity assessment, sustainability, and future governance of the IMWP.
Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasised the importance of regulatory harmonisation in ensuring patient safety and ...